AKT3 and glioma: For example, AKT3 promotes the survival of 40–60% non-hereditary melanoma cells and the development of malignant melanoma [32]; in addition, it plays an important oncogenic role in triple negative breast cancer (TNBC), colorectal cancer (CRC), invasion and metastasis of glioma, and lung cancer [2,33,34].